Closing in on HIV drug resistance.

Closing in on HIV drug resistance.

The structure of a catalytic complex of HIV-1 reverse transcriptase helps rationalize resistance mechanisms for nucleoside analog drugs.

Bibliographic Details
Main Authors:	Larder, B, Stammers, D
Format:	Journal article
Language:	English
Published:	1999

Similar Items

Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.
by: Lennerstrand, J, et al.
Published: (2001)

Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.
by: Lennerstrand, J, et al.
Published: (2001)

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.
by: Ren, J, et al.
Published: (1998)

HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance.
by: Ren, J, et al.
Published: (2005)

Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
by: Ren, J, et al.
Published: (2008)

HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis.
by: Lowe, D, et al.
Published: (1988)

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.
by: Ren, J, et al.
Published: (2000)

Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants.
by: Hopkins, A, et al.
Published: (1999)

Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors.
by: Tisdale, M, et al.
Published: (1989)

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
by: Hopkins, A, et al.
Published: (2004)

Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
by: Chamberlain, P, et al.
Published: (2002)

A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
by: Harrigan, P, et al.
Published: (2002)

Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
by: Ren, J, et al.
Published: (2006)

Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2001)

HIV and Drug-Resistant Subtypes
by: Bianca Maria Nastri, et al.
Published: (2023-01-01)

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.
by: Larder, B, et al.
Published: (1999)

Analysis of drug resistance in HIV protease
by: Shrikant D. Pawar, et al.
Published: (2018-10-01)

HIV-1 drug-resistance and drug-dependence
by: Berkhout Ben, et al.
Published: (2007-10-01)

THE GROWTH AND CHARACTERIZATION OF CRYSTALS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REVERSE-TRANSCRIPTASE
by: Jones, E, et al.
Published: (1993)

HIV Genetic Diversity and Drug Resistance
by: André F. Santos, et al.
Published: (2010-02-01)

Evolution of drug resistance in HIV protease
by: Dhara Shah, et al.
Published: (2020-12-01)

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
by: Freeman, G, et al.
Published: (2004)

Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors.
by: Ren, J, et al.
Published: (2008)

The Russian database of HIV antiretroviral drug resistance
by: Dmitry E. Kireev, et al.
Published: (2023-05-01)

Prediction and inference of dynamics in quantum plasmas
by: Larder, B
Published: (2020)

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
by: Diane E Bennett, et al.
Published: (2009-01-01)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
by: Charlotte Charpentier, et al.
Published: (2023-02-01)

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2002)

The design and development of drugs acting against the smallpox virus.
by: El Omari, K, et al.
Published: (2007)

HIV drug resistance: past and current trends
by: Ekaterina N. Ozhmegova, et al.
Published: (2022-09-01)

Tuberculosis Drug Resistance and HIV Infection, the Netherlands
by: Catharina Hendrika Haar, et al.
Published: (2007-05-01)

HIV Drug-resistant Strains as Epidemiologic Sentinels
by: María S. Sánchez, et al.
Published: (2006-02-01)

Inhibition of HIV-1 reverse transcriptase by defined template/primer DNA oligonucleotides: effect of template length and binding characteristics.
by: Idriss, H, et al.
Published: (1994)

Closing the gaps in the HIV care continuum.
by: Ruanne V Barnabas, et al.
Published: (2017-11-01)

Experience in treating drug-resistant tuberculosis in patients with HIV infection
by: A. I. Gordon, et al.
Published: (2014-12-01)

HIV REVERSE-TRANSCRIPTASE MUTATION ENABLES EVASION OF CTL MEDIATED IMMUNITY
by: Meier, U, et al.
Published: (1995)

Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2004)

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada.
by: Genevieve Rocheleau, et al.
Published: (2017-01-01)

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
by: Wainberg Mark A
Published: (2011-10-01)

The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns.
by: Marks, A, et al.
Published: (2010)